Search Results - "Vickerman, Peter"

Refine Results
  1. 1

    Global patterns of opioid use and dependence: harms to populations, interventions, and future action by Degenhardt, Louisa, Grebely, Jason, Stone, Jack, Hickman, Matthew, Vickerman, Peter, Marshall, Brandon D L, Bruneau, Julie, Altice, Frederick L, Henderson, Graeme, Rahimi-Movaghar, Afarin, Larney, Sarah

    Published in The Lancet (British edition) (26-10-2019)
    “…We summarise the evidence for medicinal uses of opioids, harms related to the extramedical use of, and dependence on, these drugs, and a wide range of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis by Platt, Lucy, Dr, Easterbrook, Philippa, MD, Gower, Erin, MPH, McDonald, Bethan, PhD, Sabin, Keith, PhD, McGowan, Catherine, PhD, Yanny, Irini, MBChB, Razavi, Homie, PhD, Vickerman, Peter, Prof

    Published in The Lancet infectious diseases (01-07-2016)
    “…Summary Background At global level, there are 37 million people infected with HIV and 115 million people with antibodies to hepatitis C virus (HCV). Little is…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed by Degenhardt, Louisa, Prof, Mathers, Bradley, MBChB, Vickerman, Peter, DPhil, Rhodes, Tim, Prof, Latkin, Carl, PhD, Hickman, Matt, Prof

    Published in The Lancet (British edition) (24-07-2010)
    “…Summary HIV can spread rapidly between people who inject drugs (through injections and sexual transmission), and potentially the virus can pass to the wider…”
    Get full text
    Journal Article
  6. 6

    Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012 by Looker, Katharine J, Magaret, Amalia S, Turner, Katherine M E, Vickerman, Peter, Gottlieb, Sami L, Newman, Lori M

    Published in PloS one (21-01-2015)
    “…Herpes simplex virus type 2 (HSV-2) infection causes significant disease globally. Adolescent and adult infection may present as painful genital ulcers…”
    Get full text
    Journal Article
  7. 7

    Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012 by Looker, Katharine J, Magaret, Amalia S, May, Margaret T, Turner, Katherine M E, Vickerman, Peter, Gottlieb, Sami L, Newman, Lori M

    Published in PloS one (28-10-2015)
    “…Herpes simplex virus type 1 (HSV-1) commonly causes orolabial ulcers, while HSV-2 commonly causes genital ulcers. However, HSV-1 is an increasing cause of…”
    Get full text
    Journal Article
  8. 8

    Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis by Looker, Katharine J, Elmes, Jocelyn A R, Gottlieb, Sami L, Schiffer, Joshua T, Vickerman, Peter, Turner, Katherine M E, Boily, Marie-Claude

    Published in The Lancet infectious diseases (01-12-2017)
    “…HIV and herpes simplex virus type 2 (HSV-2) infections cause a substantial global disease burden and are epidemiologically correlated. Two previous systematic…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    First estimates of the global and regional incidence of neonatal herpes infection by Looker, Katharine J, Dr, Magaret, Amalia S, PhD, May, Margaret T, PhD, Turner, Katherine M E, PhD, Vickerman, Peter, PhD, Newman, Lori M, MD, Gottlieb, Sami L, MD

    Published in The Lancet global health (01-03-2017)
    “…Summary Background Neonatal herpes is a rare but potentially devastating condition with an estimated 60% fatality rate without treatment. Transmission usually…”
    Get full text
    Journal Article
  12. 12

    Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis by Mountain, Elisa, Mishra, Sharmistha, Vickerman, Peter, Pickles, Michael, Gilks, Charles, Boily, Marie-Claude

    Published in PloS one (29-09-2014)
    “…We aimed to characterize the antiretroviral therapy (ART) cascade among female sex workers (FSWs) globally. We systematically searched PubMed, Embase and…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    HIV prevention is not all about HIV - using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection by Vickerman, Peter, Quaife, Matthew, Kilbourne-Brook, Maggie, Mvundura, Mercy, Eakle, Robyn, Terris-Prestholt, Fern

    Published in BMC infectious diseases (25-09-2020)
    “…In sub-Saharan Africa, considerable HIV-burden exists among women. Anti-retroviral (ARV) based prevention products could decrease this burden, and their uptake…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysis by Lim, Aaron G, Scott, Nick, Walker, Josephine G, Hamid, Saeed, Hellard, Margaret, Vickerman, Peter

    Published in PLoS medicine (19-10-2021)
    “…Modelling suggests that achieving the WHO incidence target for hepatitis C virus (HCV) elimination in Pakistan could cost US$3.87 billion over 2018 to 2030…”
    Get full text
    Journal Article
  18. 18
  19. 19

    How much demand for New HIV prevention technologies can we really expect? Results from a discrete choice experiment in South Africa by Terris-Prestholt, Fern, Hanson, Kara, MacPhail, Catherine, Vickerman, Peter, Rees, Helen, Watts, Charlotte

    Published in PloS one (30-12-2013)
    “…For the first time in the history of HIV, new bio-medical interventions have been shown to be effective in preventing HIV transmission. For these new HIV…”
    Get full text
    Journal Article
  20. 20

    The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals? by Stone, Jack, Martin, Natasha K, Hickman, Matthew, Hellard, Margaret, Scott, Nick, McBryde, Emma, Drummer, Heidi, Vickerman, Peter

    Published in PloS one (25-05-2016)
    “…The advent of highly effective hepatitis C (HCV) treatments has questioned the need for a vaccine to control HCV amongst people who inject drugs (PWID)…”
    Get full text
    Journal Article